DSM-Firmenich stock trades 0.40 percent below its yearly high

Published on 09/25/2026 at 11:38 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

DSM-Firmenich stock reported EUR 2.388 billion in Q2 2026 revenue, up 3.7 percent. A September 15 buyback update put cumulative repurchases at 6,402,212 shares.

Fotorealistisches Duftlabor mit Wissenschaftlern und Destillationsanlagen — dsm-firmenich AG (ISIN CH1216478797) betreibt moderne Duftlabore mit Wissenschaftlern und Analysegeräten für Aromastoffe, Illustration mit AI erstellt.

DSM-Firmenich stock (ISIN CH1216478797) was trading at EUR 98.96 on Euronext Amsterdam on September 25, 2026, at 11:20 a.m. CEST, up 0.71 percent from EUR 98.26. The price stood 0.40 percent below its 52-week high of EUR 99.36, giving the market a clear near-term reference point.

Stock sits near yearly high

The intraday range was EUR 98.16 to EUR 99.36, while volume reached 103,354 shares by the quoted time. Market capitalization stood at EUR 24,430,261,731 on September 25, 2026, placing the current valuation against a share price that has gained 79.20 percent from its 52-week low of EUR 55.22.

The price context matters because DSM-Firmenich stock is trading above the average analyst target shown in a recent MarketScreener overview. The average target was EUR 93.62, while the latest quoted price was EUR 98.96, a difference of EUR 5.34.

Q2 revenue reaches EUR 2.388 billion

According to Ideal Investisseur on September 16, 2026, DSM-Firmenich reported Q2 2026 revenue of EUR 2.388 billion, up 3.7 percent. EBITDA reached EUR 466 million, producing an EBITDA margin of 19.5 percent.

That combination gives investors two different signals. Revenue growth was positive at 3.7 percent, while the EUR 466 million EBITDA result and 19.5 percent margin provide the more direct test of operating execution in the latest reported quarter.

Buyback nears EUR 500 million

According to MarketScreener, DSM-Firmenich repurchased 385,000 shares from September 7 through September 11, 2026, at an average EUR 92.07 per share for EUR 35.4 million.

The same September 15, 2026 update reported 6,402,212 shares repurchased under the program at an average EUR 72.91 and total consideration of EUR 466.8 million. The capital-reduction program was intended to reach completion by the end of Q3 2026.

Next revenue update is November 3

MarketScreener lists November 3, 2026, for the next sales and revenue release. That date gives the latest Q2 margin and growth figures a defined checkpoint for the next company update.

Price remains near the yearly high

DSM-Firmenich stock was trading at EUR 98.96 on Euronext Amsterdam on September 25, 2026, at 11:20 a.m. CEST, with a daily gain of 0.71 percent and a 52-week range of EUR 55.22 to EUR 99.36.